Results 171 to 180 of about 600,809 (212)

Postmarketing surveillance for drug abuse

Drug and Alcohol Dependence, 2003
Assessing actual abuse of prescribed medications requires postmarketing surveillance. In this article we discuss general systems of postmarketing surveillance that exist as of the end of 2002 in the United States and two medication-specific surveillance systems that were devised and tested.
Theodore J. Cicero, Cynthia L. Arfken
openaire   +3 more sources

New approaches to postmarketing surveillance

Psychopharmacology, 1986
As part of a large-scale ongoing project exploring new pharmacy-based methods of postmarketing surveillance, we are comparing a patient-initiated monitoring system to a staff-initiated approach. Here we report data only from staff-initiated, computer-directed telephone interviews with 231 outpatients approximately 2 weeks after they had been prescribed
Stephen G. Bryant, Ronica M. Kluge, Seymour Fisher   +2 more
openaire   +3 more sources

Postmarketing Surveillance Methodologies

Drug Intelligence & Clinical Pharmacy, 1988
This article describes and discusses the strengths and limitations of the major pharmacoepidemiologic methodologies employed in postmarketing drug surveillance and describes the current status of the U.S. surveillance system. The main methodologies employed in postmarketing drug surveillance include controlled clinical trials, observational ...
openaire   +2 more sources

Assessing risk in postmarketing surveillance

Journal of Biopharmaceutical Statistics, 1991
We need to find some way to assess the probability of risk for individuals taking medications for a prolonged period of time either singly or, as is usually more likely, in combinations. It is not possible to perform detailed, controlled studies for all combinations of drugs, not even those most commonly administered.
J. C. Cerrito, P. B. Cerrito
openaire   +3 more sources

A Postmarket Surveillance Benchmarking Exercise

Biomedical Instrumentation & Technology, 2014
Monitoring device performance after a product has been launched is a critical aspect of maintaining product safety. Not only is it the right thing to do, but our regulators expect that it’s done. • FDA 21 CFR 822 discusses monitoring and evaluation of product performance data.
Andrea Schwartz, Pat Baird
openaire   +3 more sources

Postmarketing Surveillance in Canada

Drug Information Journal, 1996
This paper provides an overview of the history of Canada's adverse drug reaction monitoring program. The program's place within Health Canada is covered, as are development activities over the last five years. Further intentions and international harmonization initiatives are highlighted.
openaire   +2 more sources

Postmarketing Surveillance for Oncology Drugs

Clinical Journal of Oncology Nursing, 2008
Adverse effects of cancer therapies may occur more than three decades after drug administration. Continued vigilance in postmarketing use of oncology agents is necessary to accurately track adverse effects, update prescribing information, and alert healthcare providers in a timely manner.
Susan Moore, Pamela Hallquist Viale
openaire   +3 more sources

Postmarketing Surveillance [PDF]

International Journal of Pharmaceutical Medicine, 2005
The postmarketing monitoring and evaluation of the safety and effectiveness of all medicines is essential. The patterns of use, effectiveness and safety of a drug in general use may be substantially different to that in clinical trials due to differences in prescribing and patient groups; differences include the limited number of patients in studies ...
Nithya J Gogtay, Sanath Hegde, Nilima A Kshirsagar   +2 more
openaire   +1 more source

Cefmetazole postmarketing surveillance in Japan

Journal of Antimicrobial Chemotherapy, 1989
The Sankyo Company Ltd had conducted a postmarketing surveillance programme on cefmetazole sodium since its marketing introduction in Japan. Two data collection approaches were used: a survey in which participating physicians provided complete information on all their patients who received cefmetazole for treatment of infection, and two voluntary ...
openaire   +3 more sources

Postmarketing Surveillance of Drugs*

2020
Most efforts in postmarketing surveillance are directed at the design of methods to collect information on newly marketed drugs. In the review by Medicine in the Public Interest the majority of fatal adverse reactions seemed to be due to older, standard drugs.
openaire   +2 more sources